Affiliation:
1. Department of Dermatology, SRM Medical College Hospital and Research Centre, Chengalpet, Tamil Nadu, India
Abstract
Herpes zoster (HZ) is a manifestation of the reactivation of latent varicella zoster virus (VZV) infection in the dorsal root ganglion. The occurrence of HZ has been reported in association with COVID-19. Herein, we describe 10 cases who developed classic HZ within 2–3 weeks of acquiring COVID-19 infection. The triggers in these patients could be severe stress (related to quarantine issues, fear of hospitalisation and death) immune dysregulation and systemic steroid therapy in treating COVID-19. The clinical patterns and therapeutic responses observed were similar to HZ in immunocompetent persons. Increased expression of NKG2A on NK and CD8+ T cells has been proposed as a pathophysiologic mechanism in triggering HZ at the molecular level in COVID-19 patients. Primary physicians should be aware of this association to counsel and treat such patients appropriately, as initiating early treatment could minimise the risk of complications like postherpetic neuralgia.
Subject
General Materials Science
Reference7 articles.
1. Postherpetic neuralgia—pathogenesis, treatment, and prevention;Kost;N Engl J Med,1996
2. Herpes zoster might be an indicator for latent COVID 19 infection;Elsaie;Dermatol Ther,2020
3. Cutaneous manifestations in COVID-19: A first perspective;Recalcati;J Eur Acad Dermatol Venereol,2020
4. Skin manifestations associated with COVID-19: Current knowledge and future perspectives;Genovese;Dermatology,2021
5. Herpes zoster co-infection in an immunocompetent patient with COVID-19;Saati;Cureus,2020